DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up

September 13, 2018

DHPA Asks Congressional Leaders to Request CMS to Reconsider Step Therapy for Medicare Advantage Plans

DHPA joined a coalition of 240 patient and provider groups signing onto a letter to U.S. Senate and U.S. House leaders asking them to urge the Centers for Medicare & Medicaid Services (CMS) to reconsider a proposal to allow Medicare Advantage plans to implement step therapy to manage Part B drugs. CMS originally announced the proposal in August in a memo to Medicare Advantage plan sponsors.

Step therapy, sometimes known as “fail first,” is a process employed by insurers that forces patients to try therapies preferred by the insurance company before being approved for the therapy their doctor prescribed — even when doctors doubt the insurer preferred option will be effective.

The coalition writes in the letter, “Our concerns grow from the direct negative experiences that many of our organizations’ members have had with step therapy. As a result of insurers’ step therapy (also known as “fail first”) policies in the commercial market, patients have experienced delayed and restricted access to needed treatments which can impact quality of care, while physicians have experienced significantly increased administrative burdens. At a time when policymakers are seeking reforms that empower and engage patients, and reduce needless provider burden, the CMS guidance is a step in the wrong direction for Medicare and seniors.”

Click here to read the full letter.

Filed Under: Advocacy, Letters to Policymakers, Newsroom, Press Releases, Protecting Patient Access to Integrated GI Care in the Independent Setting, Resources

Member Spotlight

For more than 30 years, Akron Digestive Disease Consultants has been providing care for conditions affecting the esophagus, stomach, intestines, colon, liver, pancreas, and gall bladder. The practice currently has five board certified physicians committed to providing outstanding personalized and timely digestive health care.

Learn more at:
www.akrondigestive.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • Dr. Latha Alaparthi Named President & Board Chair of DHPA

    • Independent Healthcare Grants and Charitable Donations (Abbvie)

    • Community Grant Program (Walmart Foundation)

    • High School Outreach Curriculum and Blueprint for Session Titled: The Tools of a Gastroenterology Practice (Capital Digestive Care)

    • Pioneering Ideas: Exploring the Future to Build a Culture of Health (Robert Wood Johnson Foundation)

    • DHPA Requests Safe Harbor for Copay Coupons for Drugs with no Lower-Cost Alternative

    • Provider Groups to GOP Healthy Futures Task Force: Site Neutral Payment Reform Key to Reducing Anti-Competitive Consolidation

    • Inflammatory Bowel Disease Infographic in English and Spanish

    • Race-Based Clinical Recommendations in Gastroenterology (AGA)

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2022 · Executive Pro Theme on Genesis Framework · WordPress · Log in